Potential Role of Herbal Remedies in Stem Cell Therapy: Proliferation and Differentiation of Human Mesenchymal Stromal Cells

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2016 Aug 13

PMID 27515026

Citations 50

Authors

Vindya Lankika Udalamaththa

Chanika Dilumi Jayasinghe

Preethi Vidya Udagama

Affiliations

Soon will be listed here.

Abstract

Stem cell therapy has revolutionized modern clinical therapy with the potential of stem cells to differentiate into many different cell types which may help to replace different cell lines of an organism. Innumerous trials are carried out to merge new scientific knowledge and techniques with traditional herbal extracts that may result in less toxic, affordable, and highly available natural alternative therapeutics. Currently, mesenchyamal stromal cell (MSC) lines are treated with individual and mixtures of crude herbal extracts, as well as with purified compounds from herbal extracts, to investigate the mechanisms and effects of these on stem cell growth and differentiation. Human MSCs (hMSCs) possess multilineage, i.e., osteogenic, neurogenic, adipogenic, chondrogenic, and myogenic, differentiation abilities. The proliferative and differentiation properties of hMSCs treated with herbal extracts have shown promise in diseases such as osteoporosis, neurodegenerative disorders, and other tissue degenerative disorders. Well characterized herbal extracts that result in increased rates of tissue regeneration may be used in both stem cell therapy and tissue engineering for replacement therapy, where the use of scaffolds and vesicles with enhanced attaching and proliferative properties could be highly advantageous in the latter. Although the clinical application of herbal extracts is still in progress due to the variability and complexity of bioactive constituents, standardized herbal preparations will strengthen their application in the clinical context. We have critically reviewed the proliferative and differentiation effects of individual herbal extracts on hMSCs mainly derived from bone marrow and elaborated on the plausible underlying mechanisms of action. To be fruitfully used in reparative and regenerative therapy, future directions in this area of study should (i) make use of hMSCs derived from different non-traditional sources, including medical waste material (umbilical cord, Wharton's jelly, and placenta), (ii) take account of the vast numbers of herbal extracts used in traditional medicine globally, and (iii) investigate the mechanisms and pathways of their effects on hMSCs.

Citing Articles

Mesenchymal stem cells therapy for acute liver failure: Recent advances and future perspectives.

Luan Y, Kong X, Feng Y Liver Res. 2025; 5(2):53-61.

PMID: 39959343 PMC: 11791815. DOI: 10.1016/j.livres.2021.03.003.

Enhancement the antioxidative and immunomodulatory functions of mesenchymal stem cells by tetrandrine.

Fadaghi S, Mahmoodi M, Derakhshani A, Sedghy F, Ranjkesh M, Behzadi A Heliyon. 2024; 10(16):e35667.

PMID: 39220890 PMC: 11365297. DOI: 10.1016/j.heliyon.2024.e35667.

Enhancement of Local Osseointegration and Implant Stability of Titanium Implant in Osteoporotic Rats by Biomimetic Multilayered Structures Containing Catalpol.

Yang J, Zhang W, Lin B, Mao S, Liu G, Tan K ACS Omega. 2024; 9(27):29544-29556.

PMID: 39005760 PMC: 11238284. DOI: 10.1021/acsomega.4c02322.

Apigenin and Rutaecarpine reduce the burden of cellular senescence in bone marrow stromal stem cells.

Ali D, Okla M, Abuelreich S, Vishnubalaji R, Ditzel N, Hamam R Front Endocrinol (Lausanne). 2024; 15:1360054.

PMID: 38638133 PMC: 11024792. DOI: 10.3389/fendo.2024.1360054.

phytochemicals regulate fibroblast cell migration via modulation of focal adhesions.

Zirmire R, Saha D, Dey R, Tanimu H, Zaarour R, Bird D iScience. 2024; 27(4):109489.

PMID: 38558933 PMC: 10981128. DOI: 10.1016/j.isci.2024.109489.

References

Khakoo A, Pati S, Anderson S, Reid W, Elshal M, Rovira I . Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med. 2006; 203(5):1235-47. PMC: 2121206. DOI: 10.1084/jem.20051921. View

Ohlsson L, Varas L, Kjellman C, Edvardsen K, Lindvall M . Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol Pathol. 2003; 75(3):248-55. DOI: 10.1016/j.yexmp.2003.06.001. View

McGinley L, Sims E, Lunn J, Kashlan O, Chen K, Bruno E . Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer's Disease. Stem Cells Transl Med. 2016; 5(3):379-91. PMC: 4807660. DOI: 10.5966/sctm.2015-0103. View

Chen M, Feng W, Cao H, Zou L, Chen C, Baatrup A . A traditional Chinese medicine formula extracts stimulate proliferation and inhibit mineralization of human mesenchymal stem cells in vitro. J Ethnopharmacol. 2009; 125(1):75-82. DOI: 10.1016/j.jep.2009.06.013. View

Antebi B, Pelled G, Gazit D . Stem cell therapy for osteoporosis. Curr Osteoporos Rep. 2014; 12(1):41-7. DOI: 10.1007/s11914-013-0184-x. View

Lu D, Chen B, Liang Z, Deng W, Jiang Y, Li S . Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract. 2011; 92(1):26-36. DOI: 10.1016/j.diabres.2010.12.010. View

Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H . Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood. 2004; 104(12):3581-7. DOI: 10.1182/blood-2004-04-1488. View

Ding D, Shyu W, Lin S . Mesenchymal stem cells. Cell Transplant. 2011; 20(1):5-14. DOI: 10.3727/096368910X. View

Wang Y, Chen C . Cell adhesion and mechanical stimulation in the regulation of mesenchymal stem cell differentiation. J Cell Mol Med. 2013; 17(7):823-32. PMC: 3741348. DOI: 10.1111/jcmm.12061. View

10.

Ding Y, Xu D, Feng G, Bushell A, Muschel R, Wood K . Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes. 2009; 58(8):1797-806. PMC: 2712800. DOI: 10.2337/db09-0317. View

11.

Marion N, Mao J . Mesenchymal stem cells and tissue engineering. Methods Enzymol. 2006; 420:339-61. PMC: 4035029. DOI: 10.1016/S0076-6879(06)20016-8. View

12.

Fritz V, Jorgensen C . Mesenchymal stem cells: an emerging tool for cancer targeting and therapy. Curr Stem Cell Res Ther. 2008; 3(1):32-42. DOI: 10.2174/157488808783489462. View

13.

Potu B, Bhat K, Rao M, Nampurath G, Chamallamudi M, Nayak S . Petroleum ether extract of Cissus quadrangularis (Linn.) enhances bone marrow mesenchymal stem cell proliferation and facilitates osteoblastogenesis. Clinics (Sao Paulo). 2009; 64(10):993-8. PMC: 2763075. DOI: 10.1590/S1807-59322009001000010. View

14.

Joshi K, Bhonde R . Insights from Ayurveda for translational stem cell research. J Ayurveda Integr Med. 2014; 5(1):4-10. PMC: 4012361. DOI: 10.4103/0975-9476.128846. View

15.

Giordano A, Galderisi U, Marino I . From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol. 2007; 211(1):27-35. DOI: 10.1002/jcp.20959. View

16.

Kim D, Staples M, Shinozuka K, Pantcheva P, Kang S, Borlongan C . Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci. 2013; 14(6):11692-712. PMC: 3709752. DOI: 10.3390/ijms140611692. View

17.

Roybon L, Christophersen N, Brundin P, Li J . Stem cell therapy for Parkinson's disease: where do we stand?. Cell Tissue Res. 2004; 318(1):261-73. DOI: 10.1007/s00441-004-0946-y. View

18.

Warrier S, Haridas N, Balasubramanian S, Jalisatgi A, Bhonde R, Dharmarajan A . A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells. Cell Prolif. 2013; 46(3):283-90. PMC: 6495558. DOI: 10.1111/cpr.12026. View

19.

Rosenbaum A, Grande D, Dines J . The use of mesenchymal stem cells in tissue engineering: A global assessment. Organogenesis. 2009; 4(1):23-7. PMC: 2634175. DOI: 10.4161/org.6048. View

20.

Squillaro T, Peluso G, Galderisi U . Clinical Trials With Mesenchymal Stem Cells: An Update. Cell Transplant. 2015; 25(5):829-48. DOI: 10.3727/096368915X689622. View